An increasing number of basic and clinical studies have demonstrated a correlation between sLOX-1 levels and atherosclerotic-like diseases [10]; however, the correlation between sLOX-1 levels and the risk of stroke recurrence needs to be further investigated. Here, OLR1 is linked to stroke disorder.